These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23680817)

  • 1. Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.
    Wetherell JL; Petkus AJ; White KS; Nguyen H; Kornblith S; Andreescu C; Zisook S; Lenze EJ
    Am J Psychiatry; 2013 Jul; 170(7):782-9. PubMed ID: 23680817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study.
    Wetherell JL; Stoddard JA; White KS; Kornblith S; Nguyen H; Andreescu C; Zisook S; Lenze EJ
    Int J Geriatr Psychiatry; 2011 Aug; 26(8):869-75. PubMed ID: 20872925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.
    Schneier FR; Belzer KD; Kishon R; Amsel L; Simpson HB
    J Nerv Ment Dis; 2010 Jun; 198(6):458-61. PubMed ID: 20531128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.
    Dunlop BW; LoParo D; Kinkead B; Mletzko-Crowe T; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
    Am J Psychiatry; 2019 Apr; 176(4):275-286. PubMed ID: 30764648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial.
    Lenze EJ; Rollman BL; Shear MK; Dew MA; Pollock BG; Ciliberti C; Costantino M; Snyder S; Shi P; Spitznagel E; Andreescu C; Butters MA; Reynolds CF
    JAMA; 2009 Jan; 301(3):295-303. PubMed ID: 19155456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
    Rosnick CB; Wetherell JL; White KS; Andreescu C; Dixon D; Lenze EJ
    J Consult Clin Psychol; 2016 Apr; 84(4):345-52. PubMed ID: 26881447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.
    Dunlop BW; Kelley ME; Aponte-Rivera V; Mletzko-Crowe T; Kinkead B; Ritchie JC; Nemeroff CB; Craighead WE; Mayberg HS;
    Am J Psychiatry; 2017 Jun; 174(6):546-556. PubMed ID: 28335624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P; Lönn SL; Overø KF
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telephone-Delivered Cognitive Behavioral Therapy and Telephone-Delivered Nondirective Supportive Therapy for Rural Older Adults With Generalized Anxiety Disorder: A Randomized Clinical Trial.
    Brenes GA; Danhauer SC; Lyles MF; Hogan PE; Miller ME
    JAMA Psychiatry; 2015 Oct; 72(10):1012-20. PubMed ID: 26244854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders.
    Ciraulo DA; Barlow DH; Gulliver SB; Farchione T; Morissette SB; Kamholz BW; Eisenmenger K; Brown B; Devine E; Brown TA; Knapp CM
    Behav Res Ther; 2013 Nov; 51(11):729-35. PubMed ID: 24055681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram and suicidality in adult depression and anxiety.
    Pedersen AG
    Int Clin Psychopharmacol; 2005 May; 20(3):139-43. PubMed ID: 15812263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial.
    Stanley MA; Wilson NL; Novy DM; Rhoades HM; Wagener PD; Greisinger AJ; Cully JA; Kunik ME
    JAMA; 2009 Apr; 301(14):1460-7. PubMed ID: 19351943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of relapse in generalized anxiety disorder by escitalopram treatment.
    Allgulander C; Florea I; Huusom AK
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):495-505. PubMed ID: 16316482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
    Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
    Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining escitalopram and cognitive-behavioural therapy for social anxiety disorder: randomised controlled fMRI trial.
    Gingnell M; Frick A; Engman J; Alaie I; Björkstrand J; Faria V; Carlbring P; Andersson G; Reis M; Larsson EM; Wahlstedt K; Fredrikson M; Furmark T
    Br J Psychiatry; 2016 Sep; 209(3):229-35. PubMed ID: 27340112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a neuroimaging treatment selection biomarker for major depressive disorder.
    McGrath CL; Kelley ME; Holtzheimer PE; Dunlop BW; Craighead WE; Franco AR; Craddock RC; Mayberg HS
    JAMA Psychiatry; 2013 Aug; 70(8):821-9. PubMed ID: 23760393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting.
    Dolberg O; Larsson Lönn S; Kvist K
    Curr Med Res Opin; 2014 Jul; 30(7):1301-7. PubMed ID: 24628498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder.
    Saghafi R; Brown C; Butters MA; Cyranowski J; Dew MA; Frank E; Gildengers A; Karp JF; Lenze EJ; Lotrich F; Martire L; Mazumdar S; Miller MD; Mulsant BH; Weber E; Whyte E; Morse J; Stack J; Houck PR; Bensasi S; Reynolds CF
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1141-6. PubMed ID: 17486678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.